Xenon Pharmaceuticals Inc (XENE)
40.65
+0.55
(+1.37%)
USD |
NASDAQ |
Apr 26, 13:08
Xenon Pharmaceuticals Accounts Payable (Quarterly): 8.598M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.598M |
September 30, 2023 | 6.097M |
June 30, 2023 | 12.03M |
March 31, 2023 | 11.41M |
December 31, 2022 | 8.491M |
September 30, 2022 | 3.082M |
June 30, 2022 | 3.178M |
March 31, 2022 | 1.659M |
December 31, 2021 | 3.824M |
September 30, 2021 | 3.085M |
June 30, 2021 | 3.278M |
March 31, 2021 | 2.132M |
December 31, 2020 | 3.041M |
September 30, 2020 | 2.198M |
June 30, 2020 | 1.633M |
March 31, 2020 | 3.217M |
December 31, 2019 | 2.473M |
September 30, 2019 | 1.371M |
June 30, 2019 | 1.498M |
March 31, 2019 | 1.071M |
Date | Value |
---|---|
December 31, 2018 | 0.665M |
September 30, 2018 | 0.959M |
June 30, 2018 | 0.853M |
March 31, 2018 | 0.473M |
December 31, 2017 | 1.253M |
September 30, 2017 | 0.809M |
June 30, 2017 | 1.314M |
March 31, 2017 | 1.165M |
December 31, 2016 | 1.463M |
September 30, 2016 | 0.512M |
June 30, 2016 | 0.655M |
March 31, 2016 | 1.023M |
December 31, 2015 | 1.088M |
September 30, 2015 | 0.817M |
June 30, 2015 | 0.872M |
March 31, 2015 | 0.632M |
December 31, 2014 | 0.553M |
September 30, 2014 | 0.511M |
June 30, 2014 | 0.62M |
December 31, 2013 | 0.391M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.371M
Minimum
Sep 2019
12.03M
Maximum
Jun 2023
4.331M
Average
3.085M
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
Acasti Pharma Inc | 0.913M |
Aurinia Pharmaceuticals Inc | 4.327M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.0477M |
ESSA Pharma Inc | 2.600M |